Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells.
暂无分享,去创建一个
A. D. De Marzo | L. Sokoll | J. Isaacs | J. Arnold | L. Antony | S. Dalrymple | A. Uzgare | Yi Xu | Jurga Savaugeot | Susan Dalrymple | Susan L Dalrymple
[1] J. Isaacs,et al. Enhanced Redundancy in Akt and Mitogen-activated Protein Kinase-induced Survival of Malignant versus Normal Prostate Epithelial Cells , 2004, Cancer Research.
[2] D. Neal,et al. CD133, a novel marker for human prostatic epithelial stem cells , 2004, Journal of Cell Science.
[3] T. Kadesch,et al. Consequences of Notch-mediated induction of Jagged1. , 2004, Experimental cell research.
[4] D. French,et al. Notch1-expressing Cells Are Indispensable for Prostatic Branching Morphogenesis during Development and Re-growth Following Castration and Androgen Replacement* , 2004, Journal of Biological Chemistry.
[5] C. Korch,et al. Molecular characterization of human prostate carcinoma cell lines , 2003, The Prostate.
[6] D. Selkoe,et al. The Notch Ligands, Jagged and Delta, Are Sequentially Processed by α-Secretase and Presenilin/γ-Secretase and Release Signaling Fragments* , 2003, Journal of Biological Chemistry.
[7] A. D. De Marzo,et al. Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling? , 2003, The Journal of clinical endocrinology and metabolism.
[8] M. Loda,et al. Intermediate basal cells of the prostate: In vitro and in vivo characterization , 2003, The Prostate.
[9] Y. S. Tang,et al. Design and synthesis of highly potent benzodiazepine gamma-secretase inhibitors: preparation of (2S,3R)-3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]-diazepin-3-yl)butyramide by use of an asymmetric Ireland-Claisen rearrangement. , 2003, Journal of medicinal chemistry.
[10] W. Gage,et al. Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. , 2003, The American journal of pathology.
[11] Larry Kedes,et al. HES and HERP families: Multiple effectors of the notch signaling pathway , 2003, Journal of cellular physiology.
[12] L. Sokoll,et al. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models , 2003, The Prostate.
[13] R. Reiter,et al. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. , 2002, Molecular cancer research : MCR.
[14] J. Trent,et al. α-methylacyl-CoA racemase: A new molecular marker for prostate cancer , 2002 .
[15] J. Rhim,et al. A novel human cancer culture model for the study of prostate cancer , 2001, Oncogene.
[16] H. Koeppen,et al. Dynamics of notch expression during murine prostate development and tumorigenesis. , 2001, Cancer research.
[17] Alvin Y. Liu,et al. Characterization of cultured human prostatic epithelial cells by cluster designation antigen expression , 2001, Cell and Tissue Research.
[18] W. Isaacs,et al. A novel human cell culture model for the study of familial prostate cancer. , 2001, Cancer research.
[19] J. Isaacs,et al. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells. , 2001, Cancer research.
[20] R. Dahiya,et al. Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system , 2001, Cell Death and Differentiation.
[21] R Montironi,et al. p63 is a prostate basal cell marker and is required for prostate development. , 2000, The American journal of pathology.
[22] J. Schalken,et al. Demonstration of Intermediate Cells during Human Prostate Epithelial Differentiation In Situ and In Vitro Using Triple-Staining Confocal Scanning Microscopy , 2000, Laboratory Investigation.
[23] Graeme Irvine Stevenson,et al. L-685,458, an Aspartyl Protease Transition State Mimic, Is a Potent Inhibitor of Amyloid β-Protein Precursor γ-Secretase Activity , 2000 .
[24] J. Sklar,et al. Calcium Depletion Dissociates and Activates Heterodimeric Notch Receptors , 2000, Molecular and Cellular Biology.
[25] Raphael Kopan,et al. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. , 2000, Molecular cell.
[26] O. Pertz,et al. A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E‐cadherin homoassociation , 1999, The EMBO journal.
[27] D. S. Coffey,et al. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. , 1998, The American journal of pathology.
[28] Robert S. Kerbel,et al. E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1 , 1998, The Journal of cell biology.
[29] G. Struhl,et al. Nuclear Access and Action of Notch In Vivo , 1998, Cell.
[30] H. Bonkhoff,et al. Relation between Bcl‐2, cell proliferation, and the androgen receptor status in prostate tissue and precursors of prostate cancer , 1998, The Prostate.
[31] W. Isaacs,et al. E1A transformed normal human prostate epithelial cells contain a 16q deletion. , 1997, Cancer genetics and cytogenetics.
[32] R. K. Bright,et al. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. , 1997, Cancer research.
[33] D. Grignon,et al. Differential growth factor responses of epithelial cell cultures derived from normal human prostate, benign prostatic hyperplasia, and primary prostate carcinoma , 1996, Journal of cellular physiology.
[34] C. Disteche,et al. Chromosomal abnormalities in HPV-16-immortalized oral epithelial cells. , 1996, Carcinogenesis.
[35] R W Veltri,et al. Implication of cell kinetic changes during the progression of human prostatic cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] A. Hagemeijer,et al. Tissue culture loss of aneuploid cells from carcinomas of the prostate , 1993, Genes, chromosomes & cancer.
[37] W. Isaacs,et al. Reduction of E-Cadherin Levels and Deletion of the α-Catenin Gene in Human Prostate Cancer Cells , 1993 .
[38] W. Isaacs,et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. , 1992, Cancer research.
[39] J. Schalken,et al. Decreased expression of E-cadherin in the progression of rat prostatic cancer. , 1992, Cancer research.
[40] P. Schellhammer,et al. Cytogenetic evaluation of 20 cultured primary prostatic tumors. , 1991, Cancer genetics and cytogenetics.
[41] T. Stamey,et al. Serum-free growth of adult human prostatic epithelial cells , 1986, In Vitro Cellular & Developmental Biology.
[42] T. Stamey,et al. Serial propagation of adult human prostatic epithelial cells with cholera toxin , 1984, In Vitro.
[43] J. Lechner,et al. Growth control of prostatic carcinoma cells in serum-free media: interrelationship of hormone response, cell density, and nutrient media. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[44] E. Gindler,et al. Rapid colorimetric determination of calcium in biologic fluids with methylthymol blue. , 1972, American journal of clinical pathology.
[45] G. Aumüller,et al. Immunological characterization and activity of transglutaminases in human normal and malignant prostate and in prostate cancer cell lines , 2004, Urological Research.
[46] J. Isaacs,et al. In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue , 2004, Journal of cellular biochemistry.
[47] M. Rubin,et al. Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate. , 2001, Cancer research.
[48] T. Stamey,et al. In vitro studies of human prostatic epithelial cells: attempts to identify distinguishing features of malignant cells. , 1989, Growth factors.
[49] R. Roberts,et al. Bradykinin receptors: characterization, distribution and mechanisms of signal transduction. , 1989, Progress in growth factor research.
[50] T. Stamey,et al. Growth responses of normal, benign hyperplastic, and malignant human prostatic epithelial cells in vitro to cholera toxin, pituitary extract, and hydrocortisone , 1986, The Prostate.